Results 201 to 210 of about 200,594 (216)

Insulin Detemir Is Associated With More Predictable Glycemic Control and Reduced Risk of Hypoglycemia Than NPH Insulin in Patients With Type 1 Diabetes on a Basal-Bolus Regimen With Premeal Insulin Aspart

Diabetes Care, 2003
Philippe Vague, Jean-Louis Selam, Hanne Haahr   +2 more
exaly  

Efficacy and Safety of IDegLira Versus Basal-Bolus Insulin Therapy in Patients With Type 2 Diabetes Uncontrolled on Metformin and Basal Insulin: The DUAL VII Randomized Clinical Trial

Diabetes Care, 2018
Liana K Billings, Nikolaos Tentolouris, Esteban Jódar   +2 more
exaly  

Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial

Lancet, The, 2012
Julio Rosenstock, Allen B King, Stefano Del Prato   +2 more
exaly  

The past, present, and future of basal insulins

Diabetes/Metabolism Research and Reviews, 2016
Steven V Edelman, Jeremy Pettus, William V Tamborlane   +2 more
exaly  

Prandial Options to Advance Basal Insulin Glargine Therapy: Testing Lixisenatide Plus Basal Insulin Versus Insulin Glulisine Either as Basal-Plus or Basal-Bolus in Type 2 Diabetes: The GetGoal Duo-2 Trial

Diabetes Care, 2016
Francisco J Tinahones, Markolf Hanefeld, Julio Rosenstock   +2 more
exaly  

Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial

Lancet, The, 2012
Simon Heller, Michel Marre, John Buse
exaly  

Insulin detemir used in basal-bolus therapy in people with type 1 diabetes is associated with a lower risk of nocturnal hypoglycaemia and less weight gain over 12 months in comparison to NPH insulin

Diabetes, Obesity and Metabolism, 2005
P Vague, I de Leeuw, J W F Elte
exaly  

Effects of Adding Linagliptin to Basal Insulin Regimen for Inadequately Controlled Type 2 Diabetes: A ≥52-week randomized, double-blind study

Diabetes Care, 2013
Hannele Yki-Järvinen, Julio Rosenstock, Sandra Thiemann   +2 more
exaly  

Basal Insulin: Physiology, Pharmacology, and Clinical Implications

Postgraduate Medicine, 2011
Kevin D Niswender
exaly  

Characteristics of basal insulin requirements by age and gender in Type-1 diabetes patients using insulin pump therapy

Diabetes Research and Clinical Practice, 2005
Bret A Boyer
exaly